News

Establishing Immunotherapy For Pediatric Liver Cancer

By: 

Laurie Fickman
One of the most common forms of liver cancer in adolescents is hepatocellular carcinoma in which patient survival rates are under 30 percent. Photo courtesy: GettyImages
One of the most common forms of liver cancer in adolescents is hepatocellular carcinoma in which patient survival rates are under 30 percent. Photo courtesy: GettyImages
Associate professor of chemical and biomolecular engineering Navin Varadarajan is working to establish T-cell immunotherapy as a treatment for adolescent patients with metastatic hepatocellular liver tumors.
Associate professor of chemical and biomolecular engineering Navin Varadarajan is working to establish T-cell immunotherapy as a treatment for adolescent patients with metastatic hepatocellular liver tumors.

T-Cell Editor Creating Powerful Immunotherapy Weapon

 

As part of a $6 million effort to establish new therapies for high-risk pediatric liver cancer, Navin Varadarajan, associate professor of chemical and biomolecular engineering at the Cullen College of Engineering, will modify T cells to recognize and kill glypican-3, a molecule found in liver cancer cells.

Inherently that’s what the immune systems' white T cells do –they fight invaders or infections. It is also what Varadarajan does. With two previous awards from the Cancer Prevention & Research Institute of Texas (CPRIT), Varadarajan is working to improve effectiveness of T-cell immunotherapy. On this CPRIT multi-investigator research award, he joins Andras Heczey, a physician researcher at Baylor College of Medicine, in examining one of the most common forms of liver cancer in adolescents, hepatocellular (HCC) carcinoma. HCC patient survival rates are under 30 percent.

No effective cure is available for most metastatic hepatocellular tumors. Current treatment includes surgical resection or liver transplantation in combination with dose-intensive chemotherapy regimens -associated with significant morbidity in HCC – or which may cause low blood cell counts, hearing impairment, speech and cognitive delay and long-term damage to the heart. “It is thus critical to develop new, effective and safer therapies,” said Varadarajan.

T cell-based immunotherapy has worked in other types of cancers, like leukemia and lymphoma. The team at Baylor will isolate the T cells, modify them with synthetic receptors and then Varadarajan will get to work.

“We have a platform for documenting how well T cells work and we will use it to determine which T cell properties are essential in fighting the cancer cells,” said Varadarajan, whose team built the microscopy-based methods for monitoring cellular function.

Once determined, certain functions can be added or subtracted through genetic editing to make the T cell the best cancer fighter possible. The modified cells will deliver targeted and tailored therapy in clinical trials at Baylor.

“The hope is to get consistent and durable patient responses in pediatric HCC by using the power of immunotherapy,” said Varadarajan, who credits CPRIT with the steps forward in immunotherapy.

“Texas taxpayers are amazing for funding CPRIT. Much of this research would not be possible without it,” said Varadarajan. CPRIT’s goal is to expedite innovation in cancer research and product development, and to enhance access to evidence-based prevention programs throughout the state of Texas.

Faculty: 

Department: 

Tag: 

Related News Stories

Cullen College of Engineering posts new 6-Year graduation high mark

The six-year graduation rate for the Cullen College of Engineering is 71.2 percent for students that began in Fall 2014, the fourth year in a row it has increased.

The Cullen College of Engineering has set a new record for its six-year graduation rate, hitting a mark of 71.2 percent for students that began in Fall 2014, according to new information released by the department's Division of Undergraduate Programs and Student Success.

Researchers Take a Cue from Nature to Create Bulletproof Coatings

Alamgir Karim, Dow Chair Professor of chemical and biomolecular engineering, says the chitin project could lead to more environmentally friendly plastics and other polymers.

Shrimp, lobsters and mushrooms may not seem like great tools for the battlefield, but three engineers from the University of Houston are using chitin – a derivative of glucose found in the cellular walls of arthropods and fungi – and 3D printing techniques to produce high-impact multilayered coatings that can protect soldiers against bullets, lasers, toxic gas and other dangers.

Class of 2020 honored with virtual graduation celebration

Michelle Gale.

The fortitude of the Cullen College of Engineering's Class of 2020 was proudly celebrated by the university community on May 7, with a 90-minute virtual graduation celebration, featuring remarks from University of Houston leadership, a commencement speaker and most importantly, the graduating students.

Upcoming Events / Seminars